China Medical purchases Molecular Diagnostic's HPV detection system

10/7/2008 | Forbes

China Medical Technologies has gained rights to market a human papillomavirus detection system from Molecular Diagnostic Technologies in a $345 million deal expected to be finalized by early 2009. The agreement involves Molecular Diagnostic's HPV-DNA Biosensor Chip -- which can pinpoint 24 common HPV strains -- and Surface Plasmon Resonance-based Analysis System -- which examines data gathered from the chip.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC